BMRA - Biomerica gets EU's CE mark for its diagnostic test to detect H. pylori bacteria

Biomerica (NASDAQ:BMRA) on Thursday said it got the European Commission's CE Mark for its hp+detect diagnostic test that detects the bacteria Helicobacter pylori. BMRA stock -0.2% to $2.78 in premarket trade. The CE marking signifies that products sold in the European Economic Area have been "assessed to meet high safety, health, and environmental protection requirements." BMRA said it will begin to market and sell the hp+detect test in the European Union and other international countries following registration of the product in each country in which it is sold. Helicobacter pylori bacteria infect the stomach's lining, causing ulcers, and in some cases lead to gastric cancer. The company is still waiting for the U.S. Food and Drug Administration to clear the test.

For further details see:

Biomerica gets EU's CE mark for its diagnostic test to detect H. pylori bacteria